Voriconazole in the management of nosocomial invasive fungal infections. - Wikidata - awgldk - TriplyDB

Voriconazole in the management of nosocomial invasive fungal infections.

Voriconazole in the management of nosocomial invasive fungal infections.

http://www.wikidata.org/entity/Q35166823

about

Pharmacokinetics of voriconazole administered concomitantly with fluconazole and population-based simulation for sequential use.Medical management of invasive fungal infections of the central nervous system in pediatric cancer patients.The challenge of managing fusariosis Voriconazole therapeutic drug monitoring: focus on safety.Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.Recurrent Aspergillus terreus Endophthalmitis from Focal Bronchiectasis.Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.Deadly Sphenoid Fungus-Isolated Sphenoid Invasive Fungal Rhinosinusitis: A Case Report.Performance evaluation of enzyme immunoassay for voriconazole therapeutic drug monitoring with automated clinical chemistry analyzers.Candida krusei Empyema Thoracis: A Community-Acquired Infection Requiring a High Index of Suspicion.

P2860

Q35364006-DCE2A798-29AE-43A4-BCBD-D71CDED7932B Q35513374-9FFDA341-DB37-4EB5-A095-E41A708F1A5E Q35693680-C4A78431-2F74-4F1C-8994-E74150813392 Q37658869-DCC81434-70DD-4E84-9AE2-8B4D8D8D75E8 Q37688257-59B138B0-736C-4255-A93C-D1D70EE50E7A Q40514080-8F905462-7138-44F5-9C05-6339AEFEEE37 Q42110115-BA29BA89-DF43-46A0-A021-308E55E2EFB0 Q47157385-01B24D70-6CB5-4ECB-B756-57EACF8AE8A0 Q53090260-583CDB39-1A36-4FBC-8FB9-E641D19A6B16 Q54232730-17DCCE2B-70BA-4675-8CD6-59850612D120

P2860

Voriconazole in the management of nosocomial invasive fungal infections.

http://www.wikidata.org/entity/Q35166823

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Voriconazole in the management of nosocomial invasive fungal infections.

@ast

Voriconazole in the management of nosocomial invasive fungal infections.

@en

type

label

Voriconazole in the management of nosocomial invasive fungal infections.

@ast

Voriconazole in the management of nosocomial invasive fungal infections.

@en

prefLabel

Voriconazole in the management of nosocomial invasive fungal infections.

@ast

Voriconazole in the management of nosocomial invasive fungal infections.

@en

P1433

Q35166823-0BAB0457-2BF3-4C5F-A54E-8C4DD04D57F9

P1476

Q35166823-6EAB3DE9-041C-4EA9-9498-2EE2B9D7F3E5

P2093

Q35166823-02612160-3309-42E9-B8EB-6A9CA8DA3A99

Q35166823-23DC68E1-D491-45B8-B57B-B3682B8091DC

Q35166823-342D951F-113C-4B5E-AD33-93EE0FC96091

Q35166823-3DEEA4A8-EDC8-404A-897D-9F17420B743B

Q35166823-B3B897BD-9046-4AB6-8D0C-3DDD8BE8382C

Q35166823-CE7607F2-4D8E-4869-B481-60E8C85D8AF5

Q35166823-D6B09356-19F4-4323-B105-917D457BAAE6

Q35166823-DFB44ACA-5E8B-4B09-81FC-FC2A6A2399AF

P2860

Q35166823-017AEB1C-643D-44AC-9818-5BCBE6DFD8C7

Q35166823-029A7982-21A0-446E-AE30-7D991CE5F2C6

Q35166823-0489565A-27A2-4241-91C7-D381E11217F4

Q35166823-0AC782B4-792A-4FA6-8AC5-90EAAA0E83C8

Q35166823-0B8C423B-831D-4B90-AE0E-BE046374698D

Q35166823-0F1C74AC-16A8-46E5-9A9C-A33C8E6BD5E5

Q35166823-128EE2E7-5808-4276-B1A5-30D7B6D8A304

Q35166823-13E0DC67-0491-4460-8297-999CABFE9B68

Q35166823-13F50F5A-895E-4F69-96AF-60EB98BB6B4B

Q35166823-141FB4BD-87D2-4C36-8D6A-0C45618ED21F

P304

Q35166823-825AA522-AE6E-43A5-8980-F61A9A3DA971

P31

Q35166823-057D6EF7-F67A-4867-B2AA-8259F854D3D6

P356

Q35166823-310542F1-5E9F-4863-A9D0-947DEAEBF3CD

P433

Q35166823-FB1484D6-E6AA-451C-86BD-55E49E86C760

P478

Q35166823-4CDD54E5-0683-4098-AC35-0972109356E1

P577

Q35166823-FC975FDE-F312-4C0D-83EB-19A966259E5E

P5875

Q35166823-F0BA2BAD-A1FD-4F07-B00D-5364791D3E80

P698

Q35166823-8508D47E-F041-430B-B90F-AFD2D5198037

P932

Q35166823-D4A10917-C73F-4536-8E5C-B44578A62F5D

P356

TCRM.2006.2.2.129

P1433

Therapeutics and Clinical Risk Management

P1476

Voriconazole in the management of nosocomial invasive fungal infections.

@en

P2093

Angel Viudes

http://www.w3.org/2001/XMLSchema#string

Emilia Cantón

http://www.w3.org/2001/XMLSchema#string

Eva Romá

http://www.w3.org/2001/XMLSchema#string

Isidro Jarque

http://www.w3.org/2001/XMLSchema#string

Javier Pemán

http://www.w3.org/2001/XMLSchema#string

Miguel Gobernado

http://www.w3.org/2001/XMLSchema#string

Miguel Salavert

http://www.w3.org/2001/XMLSchema#string

Rafael Zaragoza

http://www.w3.org/2001/XMLSchema#string

P2860

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

Disseminated infection with Prototheca zopfii after unrelated stem cell transplantation for leukemia

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

In vitro activities of four novel triazoles against Scedosporium spp

In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients

In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species

In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.

P304

129-158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.2006.2.2.129

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5490978

http://www.w3.org/2001/XMLSchema#string

P698

18360588

http://www.w3.org/2001/XMLSchema#string

P932

1661660

http://www.w3.org/2001/XMLSchema#string